INTERIM REPORT Period from January 2019 to June 2019 Peptonic Medical AB (publ) org nr 556776-3064 (www.aktietorget.se ticker: PMED)
2019 FIRST QUARTER (Apr-Jun) · Net sales of products KSEK 1,011 (0) · Gross profit KSEK 768 (0), Gross margin 76% (0%) · Operating loss KSEK -5,102 (-3,563) · Loss per share SEK -0.06 (-0.04) 2019 FIRST HALF YEAR (Jan-Jun) · Net sales of products KSEK 2,481 (0) · Gross profit KSEK 1,570 (0), Gross margin 63% (0%) · Operating loss KSEK -8,287 (-6,385) · Loss per share SEK -0.09 (-0.07)From the CEO First half of the year has been very busy and successful. Early in the year, Apoteket AB decided to carry VagiVital in 30 of its largest retail shops and on-